Searchable Title

Brief Measure for Assessing Generalized Anxiety Disorder: The GAD-7. Copyright: American Medical Association.

Reference Type

Journal Article

Authors, Section

Spitzer, R. L.; Kroenke, K.; Williams, J. B.; Lowe, B.

Title, Section

Brief Measure for Assessing Generalized Anxiety Disorder: The GAD-7. Copyright: American Medical Association.

Publication Year

2006

Journal Title

Archives of Internal Medicine

Volume

166

Issue

10

Pages

1092-7

Availability

online

PMID

PMID: 16717171

DOI

10.1001/archinte.166.10.1092

Abstract

BACKGROUND: Generalized anxiety disorder (GAD) is one of the most common mental disorders; however, there is no brief clinical measure for assessing GAD. The objective of this study was to develop a brief self-report scale to identify probable cases of GAD and evaluate its reliability and validity. METHODS: A criterion-standard study was performed in 15 primary care clinics in the United States from November 2004 through June 2005. Of a total of 2740 adult patients completing a study questionnaire, 965 patients had a telephone interview with a mental health professional within 1 week. For criterion and construct validity, GAD self-report scale diagnoses were compared with independent diagnoses made by mental health professionals; functional status measures; disability days; and health care use. RESULTS: A 7-item anxiety scale (GAD-7) had good reliability, as well as criterion, construct, factorial, and procedural validity. A cut point was identified that optimized sensitivity (89%) and specificity (82%). Increasing scores on the scale were strongly associated with multiple domains of functional impairment (all 6 Medical Outcomes Study Short-Form General Health Survey scales and disability days). Although GAD and depression symptoms frequently co-occurred, factor analysis confirmed them as distinct dimensions. Moreover, GAD and depression symptoms had differing but independent effects on functional impairment and disability. There was good agreement between self-report and interviewer-administered versions of the scale. CONCLUSION: The GAD-7 is a valid and efficient tool for screening for GAD and assessing its severity in clinical practice and research.

Share

COinS